Please assess the completion status of the following clinical trial:

Trial Title: Immunostimulating Interstitial Laser Thermotherapy in Solid Cancers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Are male or female \> 18 years of age~* Have histologically confirmed, locally uncontrolled, solid cancer, with or without metastases, that cannot be treated surgically due to unresectability or inoperability~* Have one or more tumours assessable by MRI/CT or ultrasound and situated in such a way that at least a part of the tumour can be treated with IMILT without damage to surrounding vital structures or the skin~* Are candidates for ablative intervention also outside this study~* Have given informed verbal and written consent to participation in the trial~* Have an ECOG performance status \< 2 (Karnofsky \> 60%)~* Have stable haematologic, renal and hepatic functions~Exclusion Criteria:~* Are HIV positive~* Have an active autoimmune disease~* Are on systemic corticosteroid medication (local treatment with aerosol's and ointment is allowed)~* Have known bleeding disorders or are treated with anticoagulant medication~* Are pregnant or nursing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- imILT (Type: EXPERIMENTAL): Immunostimulating Interstitial Laser Thermotherapy (imILT)

Based on this trial design, predict the completion outcome and termination type (if applicable).